Skip to main content
. 2021 Apr 8;4(3):160–168. doi: 10.1007/s42058-021-00061-7

Table 1.

Clinical characteristic of the study population

All patients Common Severe
(n = 93) (n = 76) (n = 17)
Age
 Median (IQR)-y 57.0 (39.0–67.0) 53.0 (35.0–63.0) 68.0 (56.0–72.0)
 < 50 no. (%) 35 (37.6) 35 (46%) 0 (0)
  ≥ 50 no. (%) 58 (62.4) 41 (54%) 17 (100)
 Male sex no. (%) 48 (51.6) 40 (52.6) 8 (47.0)
Symptoms at admission no. (%)
 Fever 74 (79.6) 61 (80.2) 13 (76.4)
 Cough 58 (62.4) 43 (56.5) 15 (88.2)
 Sputum 32 (34.4) 24 (31.6) 8 (47.0)
 Dyspnea 39 (41.9) 28 (36.8) 11 (64.7)
Co-existing disease no. (%)
 COPD 2 (2.1) 1 (1.3) 1 (5.9)
 Diabetes 11 (11.8) 4 (5.2) 7 (41.2)
 Hypertension 19 (20.4) 13 (17.1) 6 (35.3)
 Coronary heart disease 6 (6.4) 5 (6.5) 1 (5.9)
 Cerebrovascular disease 1 (1.0) 0 (0.0) 1 (5.9)
 Time between disease onset and the first CT scan (median, IQR) (days) 4.0 (2.0–7.5) 3.0 (1.0–6.0) 7.0 (6.0–9.0)
 Mean number of CT scans 3.98 4.02 3.82
 Time between the two CT scans (median, IQR) (days) 6.0 (5.0–8.0) 6.0 (5.0–8.0) 6.0 (5.0–9.0)
Clinical outcome no. (%)
 Discharge 89 (95.7) 74 (97.4) 15 (88.2)
 Death 4 (4.3) 2 (2.6) 2 (11.8)

IQR interquartile range, COPD chronic obstructive pulmonary disease